These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 38309453)

  • 1. Comment on "Prevalence and Economic Burden of Keratoconus in the United States".
    Altamirano-Lamarque F; Oke I
    Am J Ophthalmol; 2024 Apr; 260():212. PubMed ID: 38309453
    [No Abstract]   [Full Text] [Related]  

  • 2. Response to Comment on: Prevalence and Economic Burden of Keratoconus in the United States.
    Singh RB; Parmar UPS; Jhanji V
    Am J Ophthalmol; 2024 Apr; 260():213. PubMed ID: 38309454
    [No Abstract]   [Full Text] [Related]  

  • 3. Prevalence and Economic Burden of Keratoconus in the United States.
    Singh RB; Parmar UPS; Jhanji V
    Am J Ophthalmol; 2024 Mar; 259():71-78. PubMed ID: 37951332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Author Response: The Economic Burden of Multiple Sclerosis in the United States: Estimate of Direct and Indirect Costs.
    Bebo BF
    Neurology; 2022 Nov; 99(18):819. PubMed ID: 36316125
    [No Abstract]   [Full Text] [Related]  

  • 5. Reader Response: The Economic Burden of Multiple Sclerosis in the United States: Estimate of Direct and Indirect Costs.
    Vargas WS
    Neurology; 2022 Nov; 99(18):818-819. PubMed ID: 36316124
    [No Abstract]   [Full Text] [Related]  

  • 6. Estimated Prevalence of Keratoconus in the United States From a Large Vision Insurance Database.
    Munir SZ; Munir WM; Albrecht J
    Eye Contact Lens; 2021 Sep; 47(9):505-510. PubMed ID: 34224446
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Financial Burden of Lymphedema Hospitalizations in the United States.
    Roberson ML; Strassle PD; Fasehun LO; Erim DO; Deune EG; Ogunleye AA
    JAMA Oncol; 2021 Apr; 7(4):630-632. PubMed ID: 33599683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The national economic burden of rare disease in the United States in 2019.
    Yang G; Cintina I; Pariser A; Oehrlein E; Sullivan J; Kennedy A
    Orphanet J Rare Dis; 2022 Apr; 17(1):163. PubMed ID: 35414039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Economic Burden of Adults with Major Depressive Disorder in the United States (2019).
    Greenberg P; Chitnis A; Louie D; Suthoff E; Chen SY; Maitland J; Gagnon-Sanschagrin P; Fournier AA; Kessler RC
    Adv Ther; 2023 Oct; 40(10):4460-4479. PubMed ID: 37518849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Economic Burden of Multiple Sclerosis in the United States: Estimate of Direct and Indirect Costs.
    Bebo B; Cintina I; LaRocca N; Ritter L; Talente B; Hartung D; Ngorsuraches S; Wallin M; Yang G
    Neurology; 2022 May; 98(18):e1810-e1817. PubMed ID: 35418457
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Economic Burden of Posttraumatic Stress Disorder in the United States From a Societal Perspective.
    Davis LL; Schein J; Cloutier M; Gagnon-Sanschagrin P; Maitland J; Urganus A; Guerin A; Lefebvre P; Houle CR
    J Clin Psychiatry; 2022 Apr; 83(3):. PubMed ID: 35485933
    [No Abstract]   [Full Text] [Related]  

  • 12. The lifetime economic burden of keratoconus: a decision analysis using a markov model.
    Rebenitsch RL; Kymes SM; Walline JJ; Gordon MO
    Am J Ophthalmol; 2011 May; 151(5):768-773.e2. PubMed ID: 21310384
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Keratoconus in the Medicare population.
    Reeves SW; Ellwein LB; Kim T; Constantine R; Lee PP
    Cornea; 2009 Jan; 28(1):40-2. PubMed ID: 19092403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Economic burden of urgency urinary incontinence in the United States: a systematic review.
    Coyne KS; Wein A; Nicholson S; Kvasz M; Chen CI; Milsom I
    J Manag Care Pharm; 2014 Feb; 20(2):130-40. PubMed ID: 24456314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Economic burden of multiple sclerosis in the United States: A systematic literature review.
    Schauf M; Chinthapatla H; Dimri S; Li E; Hartung DM
    J Manag Care Spec Pharm; 2023 Dec; 29(12):1354-1368. PubMed ID: 37976077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidemiology and economic burden of amyotrophic lateral sclerosis in the United States: a literature review.
    Berry JD; Blanchard M; Bonar K; Drane E; Murton M; Ploug U; Ricchetti-Masterson K; Savic N; Worthington E; Heiman-Patterson T
    Amyotroph Lateral Scler Frontotemporal Degener; 2023 Aug; 24(5-6):436-448. PubMed ID: 36748473
    [No Abstract]   [Full Text] [Related]  

  • 17. The Economic Burden of Vision Loss and Blindness in the United States.
    Rein DB; Wittenborn JS; Zhang P; Sublett F; Lamuda PA; Lundeen EA; Saaddine J
    Ophthalmology; 2022 Apr; 129(4):369-378. PubMed ID: 34560128
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Financial Toxicity in Atherosclerotic Cardiovascular Disease in the United States: Current State and Future Directions.
    Khera R; Valero-Elizondo J; Nasir K
    J Am Heart Assoc; 2020 Oct; 9(19):e017793. PubMed ID: 32924728
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Foodborne disease outbreaks in flour and flour-based food products from microbial pathogens in the United States, and their health economic burden.
    Rahman R; Scharff RL; Wu F
    Risk Anal; 2023 Dec; 43(12):2519-2526. PubMed ID: 37081547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Economic Burden of Schizophrenia in the United States.
    Kadakia A; Catillon M; Fan Q; Williams GR; Marden JR; Anderson A; Kirson N; Dembek C
    J Clin Psychiatry; 2022 Oct; 83(6):. PubMed ID: 36244006
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.